Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hematopoietic Stem Cell Transplantation"" wg kryterium: Wszystkie pola

  Lista filtrów

Ogranicz do:

Wyrównaj
Wyświetlanie 1-20 z 171210
Tytuł:
A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS).
Autorzy:
Dini N; Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Khoshbin AP; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Aliannejad R; Thoracic Research Center, Department of Internal Medicine, Division of Pulmonary and Critical Care, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Bakhshandeh H; Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Najafizadeh K; Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mehdizadeh M; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amini S; Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
Trials [Trials] 2024 Apr 06; Vol. 25 (1), pp. 243. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Bronchiolitis Obliterans Syndrome*
Pulmonary Disease, Chronic Obstructive*/diagnosis
Pulmonary Disease, Chronic Obstructive*/drug therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Tiotropium Bromide/adverse effects ; Cross-Over Studies ; Iran ; Bronchodilator Agents/adverse effects ; Double-Blind Method
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Gut diversity and the resistome as biomarkers of febrile neutropenia outcome in paediatric oncology patients undergoing hematopoietic stem cell transplantation.
Autorzy:
Sardzikova S; Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.
Andrijkova K; Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.
Svec P; Department of Paediatric Haematology and Oncology, Children's Haematology and Oncology Clinic and Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia.
Beke G; Institute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Slovakia.
Klucar L; Institute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Slovakia.
Minarik G; Medirex Group Academy N.P.O., Nitra, Slovakia.
Bielik V; Department of Biological and Medical Science, Faculty of Physical Education and Sport, Comenius University in Bratislava, Bratislava, Slovakia.
Kolenova A; Department of Paediatric Haematology and Oncology, Children's Haematology and Oncology Clinic and Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia.
Soltys K; Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 06; Vol. 14 (1), pp. 5504. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Febrile Neutropenia*
Neoplasms*
Child ; Humans ; Biomarkers ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Escherichia coli
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Robot therapy aids mental health in patients with hematological malignancy during hematopoietic stem cell transplantation in a protective isolation unit.
Autorzy:
Yamada A; Department of Hematology, Tokyo Medical University, 6-7-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. .
Akahane D; Department of Hematology, Tokyo Medical University, 6-7-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Takeuchi S; Center for Diversity, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
Miyata K; Department of Nursing, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
Sato T; Department of Nursing, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
Gotoh A; Department of Hematology, Tokyo Medical University, 6-7-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 27; Vol. 14 (1), pp. 4737. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Hematologic Neoplasms*/therapy
Hematologic Neoplasms*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Robotics*
Humans ; Hydrocortisone ; Mental Health ; Oxytocin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Extracorporeal membrane oxygenation in long-term COVID-19 with severe neutropenia and thrombocytopenia after allogeneic hematopoietic stem cell transplantation: a case report.
Autorzy:
Guo S; Department of Pulmonary and Critical Care Medicine, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China.; Department of Emergency, the Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China.
Zhang L; Department of Emergency, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Gao C; Department of Emergency, the Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China.
Lu X; Department of Emergency, the Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China.
Song W; Department of Emergency, the Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China.
Shen H; Department of Emergency, the Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China.
Guo Q; Department of Pulmonary and Critical Care Medicine, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China. .; Department of Emergency, the Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China. .; Department of Emergency and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 20; Vol. 24 (1), pp. 228. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Extracorporeal Membrane Oxygenation*/adverse effects
COVID-19*/therapy
COVID-19*/complications
Respiratory Distress Syndrome*/etiology
Thrombocytopenia*/therapy
Thrombocytopenia*/complications
Neutropenia*/complications
Neutropenia*/therapy
Neoplasms*/complications
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inventory of current practices regarding hematopoietic stem cell transplantation in metachromatic leukodystrophy in Europe and neighboring countries.
Autorzy:
Schoenmakers DH; Department of Child Neurology, Amsterdam Leukodystrophy Center, Emma's Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cellular and Molecular Mechanisms, Amsterdam Neuroscience, Amsterdam, The Netherlands.; Medicine for Society, Platform at Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Mochel F; Hôpital La Pitié-Salpêtrière, Assistance-Publique Hôpitaux de Paris, Inserm U1127, Paris, France.
Adang LA; Division of Child Neurology, Children's Hospital of Philadelphia, Philadelphia, USA.
Boelens JJ; Stem Cell Transplantation and Cellular Therapies Program, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Calbi V; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Pediatric Immunohematology Unit and Neurology and Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.; Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
Eklund EA; Section for Pediatric Neurology, Skåne University Hospital and Clinical Sciences, Lund, Lund University, 221 84, Lund, Sweden.
Grønborg SW; Center for Inherited Metabolic Diseases, Department of Pediatrics and Adolescent Medicine and Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Fumagalli F; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Pediatric Immunohematology Unit and Neurology and Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
Groeschel S; Department of Paediatric Neurology and Developmental Medicine, University Children's Hospital, Tübingen, Germany.
Lindemans C; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Wilhelmina Children's Hospital, University Medical Center Utrecht, Lundlaan 6, 3584 EA, Utrecht, The Netherlands.
Sevin C; Reference Center for Leukodystrophies, Pediatric Neurology Department, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
Schöls L; Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodeenerative Diseases (DZNE), Tübingen, Germany.
Ram D; Department of Paediatric Neurology, Royal Manchester Children's Hospital, Manchester, UK.
Zerem A; Pediatric Neurology Institute, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Graessner H; Institute for Medical Genetics and Applied Genomics, Center for Rare Diseases, University of Tübingen, Tübingen, Germany.
Wolf NI; Department of Child Neurology, Amsterdam Leukodystrophy Center, Emma's Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. .; Cellular and Molecular Mechanisms, Amsterdam Neuroscience, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Feb 07; Vol. 19 (1), pp. 46. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Leukodystrophy, Metachromatic*/therapy
Hematopoietic Stem Cell Transplantation*/methods
Humans ; Europe ; Magnetic Resonance Imaging ; Consensus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.
Autorzy:
Hirade K; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.
Kusumoto S; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
Hashimoto H; Clinical Research Management Center of Nagoya City University Hospital, Nagoya, Japan.
Shiraga K; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.
Hagiwara S; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.
Oiwa K; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.
Suzuki T; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.
Kinoshita S; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.
Ri M; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.
Komatsu H; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.
Iida S; Department of Hematology and Oncology, Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6815. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Fluconazole*/adverse effects
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Retrospective Studies ; Antifungal Agents/adverse effects ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation.
Autorzy:
Cao XH; Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Fan ZY; Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Chang YJ; Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Xu LP; Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhang XH; Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Huang XJ; Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhao XY; Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. zhao_.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Mar 06; Vol. 22 (1), pp. 244. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Epstein-Barr Virus Infections*
Humans ; Female ; Male ; Antiviral Agents ; CD8-Positive T-Lymphocytes ; Calibration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia-Single-Centre Experience.
Autorzy:
Stavi V; Soroka Medical Center, Beer Sheva 84101, Israel.
Khaire N; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.
Lipton JH; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.
Kumar R; Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 26; Vol. 31 (3), pp. 1246-1252. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Case Reports
MeSH Terms:
Anemia, Aplastic*/therapy
Hematopoietic Stem Cell Transplantation*/methods
Graft vs Host Disease*
Humans ; Retrospective Studies ; Transplantation Conditioning/methods
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation.
Autorzy:
Dogliotti, Irene (AUTHOR)
Levis, Mario (AUTHOR)
Martin, Aurora (AUTHOR)
Bartoncini, Sara (AUTHOR)
Felicetti, Francesco (AUTHOR)
Cavallin, Chiara (AUTHOR)
Maffini, Enrico (AUTHOR)
Cerrano, Marco (AUTHOR)
Bruno, Benedetto (AUTHOR)
Ricardi, Umberto (AUTHOR)
Giaccone, Luisa (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Mar2024, Vol. 16 Issue 5, p865. 19p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Early Impact of Mobilization Process on Cardiac Function and Size in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Autorzy:
Vaitiekiene, Audrone (AUTHOR)
Kulboke, Migle (AUTHOR)
Bieseviciene, Monika (AUTHOR)
Bartnykaite, Agne (AUTHOR)
Kireilis, Benas (AUTHOR)
Rinkuniene, Diana (AUTHOR)
Jankauskas, Antanas (AUTHOR)
Zemaitis, Justinas (AUTHOR)
Gaidamavicius, Ignas (AUTHOR)
Gerbutavicius, Rolandas (AUTHOR)
Vaitiekus, Domas (AUTHOR)
Vaskelyte, Jolanta Justina (AUTHOR)
Sakalyte, Gintare (AUTHOR)
Pokaż więcej
Źródło:
Journal of Clinical Medicine. Feb2024, Vol. 13 Issue 3, p773. 11p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letermovir Effectively Prevents Cytomegalovirus Infection in Patients with Aplastic Anemia After Hematopoietic Stem Cell Transplantation: A Real-World Retrospective Cohort Study.
Autorzy:
Zhang, Yuling (AUTHOR)
Chen, Xiaowei (AUTHOR)
Zhou, Ming (AUTHOR)
Zhang, Yuping (AUTHOR)
Chen, Cunte (AUTHOR)
Zhou, Ruiqing (AUTHOR)
Li, Yumiao (AUTHOR)
Yang, Fangfang (AUTHOR)
Xu, Shilin (AUTHOR)
Wang, Caixia (AUTHOR)
Zhou, Wei (AUTHOR)
Deng, Tingfen (AUTHOR)
Pan, Shiyi (AUTHOR)
Mo, Wenjian (AUTHOR)
Wang, Shunqing (AUTHOR)
Pokaż więcej
Źródło:
Infectious Diseases & Therapy. Feb2024, Vol. 13 Issue 2, p345-359. 15p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study.
Autorzy:
Gao L; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Yang L; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Tongren Hospital Shanghai Jiao Tong University School of Medicine, 111 Xianxia Road, Shanghai, China.
Zhou S; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Zhu W; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Han Y; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Chen S; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Xue S; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Wang Y; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China.
Qiu H; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. .; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China. .
Wu D; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. .; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China. .
Wu X; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. .; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China. .; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2024 Jan 29; Vol. 15 (1), pp. 24. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Graft vs Host Disease*/etiology
Myelodysplastic Syndromes*/therapy
Aged ; Humans ; Middle Aged ; Retrospective Studies ; Transplantation Conditioning ; China
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ten-Year Trends of Hematopoietic Stem Cell Transplantation in Korean Pediatric Cancer from the National Health Insurance Claims Data.
Autorzy:
Kim H; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim HJ; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jo Y; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Yoon SH; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Koh YK; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Department of Pediatrics, Chosun University College of Medicine, Gwangju, Korea.
Kang S; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Koh KN; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Im HJ; Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 294-304. Date of Electronic Publication: 2023 Sep 07.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Neoplasms*/epidemiology
Neoplasms*/therapy
Adolescent ; Humans ; Child ; Registries ; Transplantation Conditioning ; Republic of Korea/epidemiology ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Incidence and Features of Lymphoid Proliferation and Lymphomas after Solid Organ or Hematopoietic Stem Cell Transplantation in a National Database Cohort.
Autorzy:
Hahn SM; Department of Pediatric Hematology-Oncology, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Lee M; Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.
Hyun J; Division of Infectious Diseases, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.
Lim S; Department of Pediatrics, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Korea.
Kang JM; Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea.; Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea.
Ahn JG; Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea.; Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Korea.
Joo DJ; Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Jung I; Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.
Ihn K; Division of Pediatric Surgery, Severance Children's Hospital, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 305-313. Date of Electronic Publication: 2023 Jul 18.
Typ publikacji:
Journal Article
MeSH Terms:
Epstein-Barr Virus Infections*/complications
Lymphoma*/epidemiology
Lymphoma*/etiology
Lymphoma*/therapy
Lymphoproliferative Disorders*/epidemiology
Lymphoproliferative Disorders*/etiology
Lymphoproliferative Disorders*/diagnosis
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Child ; Young Adult ; Adult ; Adolescent ; Infant, Newborn ; Infant ; Child, Preschool ; Incidence ; Cohort Studies ; Cell Proliferation ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases.
Autorzy:
Song X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Qi J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Li X; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Zhou M; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
He J; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
Chu T; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.
Han Y; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.; Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.; State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China.
Pokaż więcej
Źródło:
Platelets [Platelets] 2023 Dec; Vol. 34 (1), pp. 2229905.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Myelodysplastic Syndromes*/therapy
Humans ; Retrospective Studies ; Platelet Transfusion/adverse effects ; Splenomegaly/etiology ; Prognosis ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia.
Autorzy:
Cao J; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Xu X; Department of Oncology, The First Affiliated Hospital of Ningbo University, Ningbo, People's Republic of China.
Lu Y; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Wang T; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Chen D; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Li S; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Liu X; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Ye P; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Zheng ZZ; Shanghai Tissuebank Biotechnology Co., Ltd., Shanghai, People's Republic of China.
Pei R; Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.; Institute of Hematology, Ningbo University, Ningbo, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2223873.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/drug therapy
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematologic Neoplasms*/therapy
Adult ; Humans ; Child ; Cyclophosphamide/therapeutic use ; Busulfan/therapeutic use ; Antilymphocyte Serum/therapeutic use ; Acute Disease ; Transplantation Conditioning ; Cytarabine/therapeutic use ; Recurrence ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Allogeneic hematopoietic stem cell transplantation for B-cell lymphoma in Taiwan.
Autorzy:
Lee CH; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Lin TC; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Yao M; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, Taipei, Taiwan.
Hsiao LT; Division of Hematology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Ko BS; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, Taipei, Taiwan.; Department of Hematological Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
Liu CJ; Division of Hematology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan.
Chen TY; Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Center for Cell Therapy, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (24), pp. 21761-21769. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Lymphoma, Large B-Cell, Diffuse*
Graft vs Host Disease*/etiology
Humans ; Transplantation, Autologous ; Transplantation, Homologous ; Taiwan/epidemiology ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 171210

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies